These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

950 related items for PubMed ID: 11742418

  • 1. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium.
    Papp C, Schatz F, Krikun G, Hausknecht V, Lockwood CJ.
    Early Pregnancy (Cherry Hill); 2000 Oct; 4(4):230-9. PubMed ID: 11742418
    [Abstract] [Full Text] [Related]

  • 2. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell stromelysin-1 and prolactin expression.
    Schatz F, Papp C, Aigner S, Krikun G, Hausknecht V, Lockwood CJ.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):188-93. PubMed ID: 8989257
    [Abstract] [Full Text] [Related]

  • 3. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
    Lockwood CJ, Krikun G, Papp C, Aigner S, Schatz F.
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
    [Abstract] [Full Text] [Related]

  • 4. A biological model for the regulation of peri-implantational hemostasis and menstruation.
    Lockwood CJ, Schatz F.
    J Soc Gynecol Investig; 1996 Apr; 3(4):159-65. PubMed ID: 8796825
    [Abstract] [Full Text] [Related]

  • 5. Implications of decidualization-associated protease expression in implantation and menstruation.
    Schatz F, Krikun G, Runic R, Wang EY, Hausknecht V, Lockwood CJ.
    Semin Reprod Endocrinol; 1999 Apr; 17(1):3-12. PubMed ID: 10406070
    [Abstract] [Full Text] [Related]

  • 6. Regulation of plasminogen activator inhibitor 1 expression by interaction of epidermal growth factor with progestin during decidualization of human endometrial stromal cells.
    Lockwood CJ.
    Am J Obstet Gynecol; 2001 Apr; 184(5):798-804; discussion 804-5. PubMed ID: 11303186
    [Abstract] [Full Text] [Related]

  • 7. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
    Nordengren J, Pilka R, Noskova V, Ehinger A, Domanski H, Andersson C, Høyer-Hansen G, Hansson SR, Casslén B.
    Mol Hum Reprod; 2004 Sep; 10(9):655-63. PubMed ID: 15243126
    [Abstract] [Full Text] [Related]

  • 8. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
    Norwitz ER, Snegovskikh V, Schatz F, Foyouzi N, Rahman M, Buchwalder L, Lee HJ, Funai EF, Buhimschi CS, Buhimschi IA, Lockwood CJ.
    Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
    [Abstract] [Full Text] [Related]

  • 9. The decidua regulates hemostasis in human endometrium.
    Lockwood CJ, Krikun G, Schatz F.
    Semin Reprod Endocrinol; 1999 Apr; 17(1):45-51. PubMed ID: 10406075
    [Abstract] [Full Text] [Related]

  • 10. The role of progestationally regulated stromal cell tissue factor and type-1 plasminogen activator inhibitor (PAI-1) in endometrial hemostasis and menstruation.
    Lockwood CJ, Krikun G, Papp C, Toth-Pal E, Markiewicz L, Wang EY, Kerenyi T, Zhou X, Hausknecht V, Papp Z.
    Ann N Y Acad Sci; 1994 Sep 30; 734():57-79. PubMed ID: 7978955
    [Abstract] [Full Text] [Related]

  • 11. The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding.
    Schatz F, Guzeloglu-Kayisli O, Arlier S, Kayisli UA, Lockwood CJ.
    Hum Reprod Update; 2016 Jun 30; 22(4):497-515. PubMed ID: 26912000
    [Abstract] [Full Text] [Related]

  • 12. The role of decidualization in regulating endometrial hemostasis during the menstrual cycle, gestation, and in pathological states.
    Lockwood CJ, Krikun G, Rahman M, Caze R, Buchwalder L, Schatz F.
    Semin Thromb Hemost; 2007 Feb 30; 33(1):111-7. PubMed ID: 17253197
    [Abstract] [Full Text] [Related]

  • 13. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
    Lockwood CJ, Krikun G, Aigner S, Schatz F.
    J Clin Endocrinol Metab; 1996 Jan 30; 81(1):107-12. PubMed ID: 8550736
    [Abstract] [Full Text] [Related]

  • 14. Biological mechanisms underlying RU 486 clinical effects: inhibition of endometrial stromal cell tissue factor content.
    Lockwood CJ, Krikun G, Papp C, Aigner S, Nemerson Y, Schatz F.
    J Clin Endocrinol Metab; 1994 Sep 30; 79(3):786-90. PubMed ID: 8077362
    [Abstract] [Full Text] [Related]

  • 15. Matrix metalloproteinase and matrix metalloproteinase inhibitor expression in endometrial stromal cells during progestin-initiated decidualization and menstruation-related progestin withdrawal.
    Lockwood CJ, Krikun G, Hausknecht VA, Papp C, Schatz F.
    Endocrinology; 1998 Nov 30; 139(11):4607-13. PubMed ID: 9794472
    [Abstract] [Full Text] [Related]

  • 16. Progesterone induces the fibulin-1 expression in human endometrial stromal cells.
    Nakamoto T, Okada H, Nakajima T, Ikuta A, Yasuda K, Kanzaki H.
    Hum Reprod; 2005 Jun 30; 20(6):1447-55. PubMed ID: 15774544
    [Abstract] [Full Text] [Related]

  • 17. Trimegestone differentially modulates the expression of matrix metalloproteinases in the endometrial stromal cell.
    Wahab M, Taylor AH, Pringle JH, Thompson J, Al-Azzawi F.
    Mol Hum Reprod; 2006 Mar 30; 12(3):157-67. PubMed ID: 16556677
    [Abstract] [Full Text] [Related]

  • 18. Tibolone and its metabolites enhance tissue factor and PAI-1 expression in human endometrial stromal cells: Evidence of progestogenic effects.
    Schatz F, Kuczynski E, Kloosterboer HJ, Buchwalder L, Tang C, Krikun G, Lockwood CJ.
    Steroids; 2005 Nov 30; 70(12):840-5. PubMed ID: 16011840
    [Abstract] [Full Text] [Related]

  • 19. Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium.
    Slayden OD, Nayak NR, Burton KA, Chwalisz K, Cameron ST, Critchley HO, Baird DT, Brenner RM.
    J Clin Endocrinol Metab; 2001 Jun 30; 86(6):2668-79. PubMed ID: 11397870
    [Abstract] [Full Text] [Related]

  • 20. The possible use of antiprogestins for contraception.
    Bygdeman M, Danielsson KG, Swahn ML.
    Acta Obstet Gynecol Scand Suppl; 1997 Jun 30; 164():75-7. PubMed ID: 9225644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.